Ventilator associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment ScienceDirect Ventilator Associated Pneumonia (VAP) EMCrit Project Ventilator associated pneumonia (VAP) and pleural empyema caused by multidrug resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report ScienceDirect Ventilator Associated Pneumonia Medicine Question Bank VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds